semaglutide ad Novo Nordisk calls out dangers of compounded GLP-1s in new DTC Ad for Novo Nordisk's

No, you dont have to stay on semaglutide indefinitely

In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost ~28.7% of body weight (~71 lbs at 68 weeks) and saw substantial improvements in pain and function: WOMAC pain scores reduced by 4.5 points (75.8%) Meaningful gains in physical function, with many patients essentially free of knee pain by study end If these results are confirmed in broader use, were not just talking about weight loss drugs anymorewere talking about disease-modifying therapies that simultaneously target obesity, pain, mobility, and downstream CV risk

If so, we have great news

Improved overall health: In addition to shedding pounds, many patients see improvements in cholesterol, blood pressure, and blood sugar levels